𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of friend erythroleukemic cell differentiation by bromodeoxyuridine: Correlation with the amount of bromodeoxyuridine in dna

✍ Scribed by Charles R. Ashman; Richard L. Davidson


Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
484 KB
Volume
102
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

These studies were undertaken to examine the relationship between the inhibition by 5‐bromodeoxyuridine (BrdU) of erythroid differentiation in Friend erythroleukemia cells and the incorporation of BrdU into DNA. Experiments were carried out in which the incorporation of BrdU into DNA and the concentration of BrdU to which the cells were exposed were varied independently of each other. In addition, the ability of deoxycytidine (dC) to reverse the effects of BrdU on hemoglobin production and to reduce the amount of BrdU in DNA was analyzed. Under all the conditions tested, the effects of BrdU were correlated with the amount of Brd incorporated into nuclear DNA. These results differ from those of recent studies on the inhibition of pigmentation and the induction of mutations by BrdU in Syrian hamster melanoma cells. The results suggest that BrdU may be producing its biological effects by a variety of different mechanisms.


πŸ“œ SIMILAR VOLUMES


The requirement of DNA synthesis for the
✍ John Morrow; Douglas M. Stocco; Joe A. Fralick πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 722 KB

## Abstract Non‐lethal concentrations of bromodeoxyuridine induce a 2‐ to 5‐fold increase in the specific activity of alkaline phosphatase in HeLa subclone, S3G. Experiments employing 10‐hour pulses of BRdU showed that 48 hours were required before induction commenced, and that maximal induction wa

p53 status correlates with the different
✍ George Xinarianos; Triantafillos Liloglou; Wendy Prime; George Sourvinos; Andrea πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 855 KB

We examined the p53 status of 108 NSCLCs compared to the expression of MLH1 and MSH2 proteins. p53 overexpression was demonstrated by IHC in 64% of patients examined, whereas p53 mutations were detected in 43%. Twenty-two percent of mutations were located outside of the hot-spot (exons 5-8) area. p5